Nasdaq
PMCB
PharmaCyte Biotech, Inc.
- Health Care
- 1 day
- +0.0%
- 1 month
- −17.0%
- 1 year
- −30.6%
$0.5901 · Mkt cap $6.34M
At the 6 Aug 2026 close
Nasdaq
PharmaCyte Biotech, Inc.
$0.5901 · Mkt cap $6.34M
At the 6 Aug 2026 close
PharmaCyte Biotech, Inc. trades under the ticker PMCB on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). Its market capitalisation is $6.34M. The last closing price was $0.5901, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −30.6%, and −17.0% over the past month. Returns are price returns and exclude dividends.
This page exists because PMCB is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.